This course explores personalised treatment in metastatic breast cancer, highlighting the role and clinical benefits of low-dose metronomic chemotherapy with oral agents.... See more
This CME presents an expert interview on targeted therapy in FLT3-ITD–positive AML, focusing on clinical evidence for quizartinib and its application in clinical practice.... See more